MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 50 filers reported holding MIRATI THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,048,067 | -28.8% | 28,189 | -13.2% | 0.00% | -33.3% |
Q4 2022 | $1,472,122 | -69.8% | 32,490 | -55.3% | 0.01% | -77.8% |
Q2 2022 | $4,882,000 | +272.7% | 72,722 | +356.2% | 0.03% | +440.0% |
Q1 2022 | $1,310,000 | +310.7% | 15,940 | +785.1% | 0.01% | +400.0% |
Q3 2021 | $319,000 | -80.9% | 1,801 | -82.6% | 0.00% | -83.3% |
Q2 2021 | $1,669,000 | +50.2% | 10,330 | +104.2% | 0.01% | -25.0% |
Q4 2020 | $1,111,000 | -20.8% | 5,058 | -53.5% | 0.01% | 0.0% |
Q4 2019 | $1,402,000 | +34.8% | 10,879 | +7.7% | 0.01% | -20.0% |
Q2 2019 | $1,040,000 | -82.9% | 10,100 | -87.8% | 0.01% | -84.4% |
Q1 2019 | $6,078,000 | +443.2% | 82,924 | +214.4% | 0.06% | +392.3% |
Q4 2018 | $1,119,000 | +156.7% | 26,379 | +85.8% | 0.01% | +85.7% |
Q1 2018 | $436,000 | +78.0% | 14,200 | -32.3% | 0.01% | +40.0% |
Q3 2017 | $245,000 | – | 20,975 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |